• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen

by Jasmine Pennic 06/05/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen

Glooko and Companion Medical have announced an integrated data partnership agreement that will enable insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App.

Impact of Integration

The announcement of this integration is significant because InPen is the first “smart” insulin pen to introduce its data integration and compatibility with the Glooko platform in the U.S. More than 70 percent of the 7.4 million insulin users in the U.S. take their insulin via MDI, and of those, approximately half take it using an insulin pen. The partnership allows people living with diabetes who use InPen to integrate their multiple daily injection regimen data, both long-acting and rapid-acting, into the Glooko diabetes data platform. 

InPen Overview

The InPen system combines a Bluetooth®-enabled insulin pen and an easy-to-use app to provide constant tracking, monitoring, and calculating of insulin for successful diabetes management. InPen empowers users to manage their diabetes simply and accurately featuring smart dosing, smart settings, and smart reminders.

“We are excited to launch support for InPen on the Glooko platform,” said Russ Johannesson, CEO of Glooko. “InPen is an innovative solution for calculating insulin doses and tracking insulin injection data. We feel users will get tremendous value out of seeing this data correlated with the food, activity, and glucose information in Glooko to help them make informed treatment decisions when they dose and see diabetes insights and trends over time that may not have been previously known.”

InPen is available in the U.S. by prescription only. The Glooko Mobile App is available for free download in the Apple Store and Android Play.

YouTube video
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: apple, Bluetooth, Data Integration, data management, diabetes, Diabetes Management, digital diabetes management platform, Glooko, insulin, smart insulin pen cap

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

10 Critical KPIs Every Successful Healthcare Organization is Implementing10 Critical KPIs Every Successful Healthcare Organization is Implementing

How to Build Hybrid Care Models Around Remote Patient Monitoring

How to Build Hybrid Care Models Around Remote Patient Monitoring

Most Popular

M&A: Florence Acquires Virtual Care Solution Zipnosis

M&A: Florence Acquires Virtual Care Solution Zipnosis

Adopting Value-Based Care Models for Autism Care Is Imperative

Why Adopting Value-Based Care Models for Autism Care Is Imperative

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

Vanderbilt University Medical Center Taps Philips Reduce Carbon Footprint

Vanderbilt University Medical Center Taps Philips to Reduce Carbon Footprint

Denials Management Named Most Time-Consuming Task in RCM

Denials Management Named Most Time-Consuming Task in RCM

How AI Can Eliminate Surprise Bills, Improve Payment Integrity

AI Can Eliminate Surprise Bills, Improve Payment Integrity

Q/A: IQVIA’s Global Lead Talks Unlocking AI for Drug Repurposing

M&A: Kaiser Acquires Geisinger, Forms Risant Health

5 Executives Weigh in on VBC Impact on Kaiser/Geisinger Deal

Digital Health Executive Hires & Departures

Digital Health Executive Hires & Departures: Ed Marx Departure, Particle Health CEO, Rhapsody CFO, Others

Catalyst by Wellstar Launches $100M Digital Health Venture Fund

Catalyst by Wellstar Launches $100M Digital Health Venture Fund

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |